Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Effect of the anti-cancer preparation NSC-631570 (UKRAIN) on malignant melanoma


Wassil Nowicky

Ukrainian Anti-Cancer Institute, Austria

: J Clin Exp Oncol

Abstract


In a series of articles the researchers have studied the effect of NSC‐631570 on various parameters in breast cancer patients. Best results were achieved with higher dosage of NSC‐631570. Almost every patient noted the improvement of the general well‐being, sleep and appetite. During the surgery, the tumors as well as involved lymph nodes were presented sclerotic and well demarcated from the surrounding tissue. This alleviated the surgical removal of the tumor considerably. In the tumor tissue, increased concentration of the amino acid proline was revealed indicating augmented production of connective tissue that 16 demarcate the tumor from surrounding tissue. NSC‐631570 improved also the amino acid balance of patients. A recent in vitro study with murine and human cancer cell lines confirmed these good results in the treatment of breast cancer were not accidental. The researchers from Emory University (Atlanta, Georgia, USA) and Kennesaw State University (Kennesaw, Georgia, USA) concluded: “The anticancer drug Ukrain exerts its cytotoxic effects on both mouse and human breast cancer cell lines in a dose and time dependent manner. Weeks following Ukrain treatment, cells maintained a reduced capacity to proliferate. Our data suggest that Ukrain could be effective as an anticancer drug for breast cancer due to its short term and long term inhibitory effects on tumor cell viability and proliferation.”

Biography


Wassil Nowicky is the Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). He is the inventor of the anti-cancer preparation on the basis of celandine alkaloids “NSC-631570”. He is an author of over 300 scientific articles dedicated to cancer research. He is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name of Albert Schweizer. He has received the award for merits of National guild of pharmacists of America, the award of Austrian Society of sanitary, hygiene and public health services and others.

E-mail: [email protected]

Track Your Manuscript

Media Partners

GET THE APP